PAVmed Inc. (PAVM) Form 10-K Annual Reports
PAVmed Inc. (PAVM) is a publicly traded company on the Nasdaq, categorized under SIC 3841 (Surgical & Medical Instruments & Apparatus). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: PAVM
CIK: 1624326
Exchange: Nasdaq
SIC 3841: Surgical & Medical Instruments & Apparatus
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
CBIZ CPAs P.C.
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerJin Dong
Audit LocationNew York, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-10 | 2026-09-09 | 8-K | 0001493152-26-042021 | View SEC Doc Filr Page |
| 424B5 | 2026-09-10 | — | 424B5 | 0001493152-26-042020 | View SEC Doc Filr Page |
| 8-K | 2026-08-14 | 2026-08-14 | 8-K | 0001493152-26-038072 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0001094891-26-000279 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | FORM 10-Q | 0001437749-26-027733 | View SEC Doc Filr Page |
| S-8 | 2026-07-30 | — | S-8 | 0001493152-26-035296 | View SEC Doc Filr Page |
| 8-K | 2026-06-24 | 2026-06-24 | 8-K | 0001493152-26-029944 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-15 | — | SCHEDULE 13G Filing | 0001011438-26-000349 | View SEC Doc Filr Page |
| 8-K | 2026-05-15 | 2026-05-15 | 8-K | 0001493152-26-023352 | View SEC Doc Filr Page |
| 10-Q | 2026-05-14 | 2026-03-31 | FORM 10-Q | 0001437749-26-017121 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-14 | — | SCHEDULE 13G Filing | 0000728083-26-000004 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-11 | — | SCHEDULE 13G/A Filing | 0001493152-26-022317 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-30 | 2026-04-30 | DEF 14A | 0001493152-26-020705 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-30 | — | DEFA14A | 0001493152-26-020713 | View SEC Doc Filr Page |
| ARS | 2026-04-30 | 2025-12-31 | ARS | 0001493152-26-020710 | View SEC Doc Filr Page |
| EFFECT | 2026-04-29 | — | EFFECT Filing | 9999999995-26-001387 | View SEC Doc Filr Page |
| 424B3 | 2026-04-29 | — | 424B3 | 0001493152-26-019594 | View SEC Doc Filr Page |
| CORRESP | 2026-04-27 | — | CORRESP Filing | 0001493152-26-019087 | View SEC Doc Filr Page |
| UPLOAD | 2026-04-24 | — | UPLOAD Filing | 0000000000-26-004245 | View SEC Doc Filr Page |
| S-3 | 2026-04-21 | — | S-3 | 0001493152-26-018158 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-04-14 | — | SCHEDULE 13G/A Filing | 0001104659-26-043174 | View SEC Doc Filr Page |
| 4 | 2026-04-13 | 2026-04-02 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001094891-26-000191 | View SEC Doc Filr Page |
| 3 | 2026-04-13 | 2026-03-24 | INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | 0001094891-26-000187 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-04-13 | — | SCHEDULE 13G Filing | 0002128174-26-000001 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-04-09 | — | SCHEDULE 13D Filing | 0001094891-26-000179 | View SEC Doc Filr Page |